About
Oncobit develops and commercializes liquid biopsy monitoring solutions that quantify circulating tumor DNA (ctDNA) from blood samples using a CE‑IVDR–marked digital PCR platform to support personalized cancer monitoring and treatment decision-making.
Explore Oncobit AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.